Why Pfizer's Headwinds May Already Be In The Price

Pfizer (NYSE: PFE ) faces several headwinds ranging from patent expirations to COVID product declines and competition from generics. Some of these factors have mostly played out, like the COVID product cliff, while the others are already acknowledgedI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice ...